Introduction {#Sec1}
============

Orphan nuclear receptor Nur77 (also called TR3, NGFI-B, or NR4A1) is a member of the NR4A family of nuclear receptors. Similar to other nuclear receptors, Nur77 consists of an N-terminal transactivation domain, a central DNA binding domain and a C-terminal ligand binding domain, and can act in the nucleus as a ligand-independent and constitutively active transcription factor by binding to its DNA response elements as monomers \[[@CR1]\], homodimers \[[@CR2]\] or heterodimers with retinoid X receptor \[[@CR2]\]. Unlike other nuclear receptors, Nur77 and other members of the subfamily are classified as early response genes whose expression is induced by a diverse range of extracellular stimuli including a wide array of cytokines and growth factors \[[@CR3]\]. Consistently, accumulating studies indicate that Nur77 is implicated in the control of inflammatory diseases including atherosclerosis \[[@CR4]\], arthritis \[[@CR5]\], inflammatory bowel disease (IBD) \[[@CR6]\] and cancer \[[@CR7]\]. Nur77 is aberrantly expressed in atherosclerotic lesions \[[@CR8]\], and cancer \[[@CR7]\]. Nur77 may act to mediate pro-inflammatory signalling by increasing the expression of NF-κB-activating kinase, IKKi \[[@CR9]\] to attenuate cytokine signalling. However, recent in vivo studies have shown that Nur77 is protective against the development of atherosclerosis by regulating the polarization of macrophages and subsequently inhibits inflammatory responses \[[@CR10]\], indicating Nur77 may mediate anti-inflammatory signalling. Despite all of these efforts, however, the in vivo roles and underlying mechanism of Nur77 in sepsis are unclear.

Tumor necrosis factor receptor associated factor 6 (TRAF6), a member of TRAF family, is a common signalling mediator for the TLR-IL-1R superfamily \[[@CR11]\]. TRAF6-deficient mice have defects in TLR-IL-1R-initiated inflammatory signalling \[[@CR12]\]. TRAF6 is reported to possess an E3 ubiquitin ligase and undergoes lysine 63 (K63)-linked auto-ubiquitination \[[@CR13]\]. The modification, in contrast to K48-linked polyubiquitin conjugation, is not associated with proteasomal degradation but instead facilitates signal transduction and protein trafficking \[[@CR14], [@CR15]\]. The regulatory involvement of various molecules in TRAF6-mediated TLR-IL-1R signalling has been confirmed. β-arrestin act as negative regulators to prevent ubiquitination of TRAF6 through direct interaction, which effectively blocks excessive inflammatory responses \[[@CR16]\]. In contrast, the formation of TRAF6-HSP27 complex promotes TRAF6 ubiquitination and enhances activation of NF-κB signalling triggered by IL-1β \[[@CR17]\].

Here, we investigate the in vivo function of Nur77 in sepsis and sepsis-associated liver injury. Our work indicates that Nur77 deficiency in mice increased their susceptibility to LPS-induced sepsis and acute liver injury, and reveal a critical mechanism wherein Nur77 interacts with TRAF6 and regulate its auto-ubiquitination in in vivo mouse model of sepsis.

Materials and methods {#Sec2}
=====================

Mice {#Sec3}
----

Nur77-knockout mice were purchased from Jackson Laboratory (Bar Harbor, ME). Mice were maintained in a pathogen-free environment as recently described \[[@CR6]\]. All animal experiments were performed in accordance with the regulations and guidelines of the Animal Care and Use Committee of Soochow University.

Sepsis model {#Sec4}
------------

The age- and sex-matched Nur77^+/+^ versus Nur77^−/−^ mice were injected with LPS (20 mg/kg, ip). Then, 2 h later, hepatic *Tnf*, *Il6,* and *Il12b* mRNA was measured by RT-PCR and Real-time PCR. TNFα and IL-6 in blood were measured with ELISA. To induce endotoxic shock, mice were injected with LPS (20 mg/kg, ip) and were monitored for survival for the ensuing 72 h.

Acute liver injury model {#Sec5}
------------------------

Nur77^+/+^ and Nur77^−/−^ mice used for the model were 8--10 weeks of age and were matched for age and sex. Mice were co-injected with LPS (5 μg/kg, ip) and D-GalN (400 mg/kg). 5 h later, mice were anesthetized with ether and retro-orbitally bled. ALT, AST, TNFα, and IL-6 were measured with ELISA. Also, RNA was extracted from liver tissue and relative mRNA of *Tnf*, *Il6,* and *Il12b* were measured by RT-PCR and Real-time PCR. Mice were monitored for 24 h to assess survival.

Tissue samples collection and evaluation {#Sec6}
----------------------------------------

Pathological analysis of lung, liver and kidney from Nur77^+/+^ and Nur77^−/−^ mice was conducted and tissue samples were fixed in 10 % buffered formalin and then embedded in paraffin. Tissue was sectioned and stained with hematoxylin and eosin (H&E) according to standard histological procedures.

Real-time PCR assays {#Sec7}
--------------------

Real-time PCR assays were performed as published \[[@CR7], [@CR18]\]. The abundance of each mRNA was normalized relative to PCR with the housekeeping gene β-actin. The primers for PCR reactions are listed in Table [1](#Tab1){ref-type="table"}.Table 1Primers for real-time PCRMouse gene name      Forward/reverse  *Tnf*  F: 5'-CTCACACTCAGATCATCTTCTC-3'  R: 5'-CTTTCTCCTGGTATGAGATAGC-3'  *Il6*  F: 5'-TTCCATCCAGTTGCCTTCTTG-3'  R: 5'-AGGTCTGTTGGGAGTGGTATC-3'  *Il12*  F: 5'- CAACATCAAGAGCAGTAGCAG-3'  R: 5'- TACTCCCAGCTGACCTCCAC-3'  *β-actin*  F: 5'-TGGAATCCTGTGGCATCCATGAAAC-3'  R: 5'-TAAAACGCAGCTCAGTAACAGTCCG-3'

ELISA {#Sec8}
-----

ALT, AST, TNFα, and IL-6 in serum were measured with commercially available kits according to the manufacturer's instructions.

Western blot {#Sec9}
------------

Western blot analyses were performed as described in the literature \[[@CR7]\].

Immunoprecipitation and ubiquitination Assay {#Sec10}
--------------------------------------------

Cells were lysed in lysis buffer (2 mmol/L Tris--HCl (pH 7.4), 10 mmol/L EDTA, 100 mmol/L NaCl and 1 % IGEPAL). Cell lysates were incubated with indicated antibodies in protein A/G beads (Santa Cruz Biotechnology) for 3 h. Then, the protein-antibody complexes on the beads were analyzed with Western blot. To measure TRAF6 ubiquitination, 10 mM N-ethylmaleimide (Sigma) was included in the lysis buffer.

Statistical analysis {#Sec11}
--------------------

Data are expressed as means ± SD, and Student's *t* test (unpaired, two-tailed) was used to compare two groups of independent samples (*p* \< 0.05 were considered statistically significant).

Results and discussion {#Sec12}
======================

Research suggests that orphan nuclear receptor Nur77 is implicated in inflammation and immunity. Mice lacking all Nr4a receptors including Nur77 did not generate T~reg~ cells and resulted in systemic autoimmune disease \[[@CR19]\]. Nur77 deficiency in mice lead to acceleration of atherosclerosis \[[@CR10]\] and inflammatory bowel disease \[[@CR6]\]. We recently reported that loss of Nur77 in older mice contributes to systemic inflammation \[[@CR20]\]. Sepsis, the major complication of severe infection, usually causes multisystem organ failure and even death of many patients in hospital \[[@CR21]\]. Therefore, it is of great importance to find the new potential targets for sepsis treatment. Here we investigate in vivo functions of Nur77 in sepsis and sepsis-associated liver injury. We first challenged Nur77^−/−^ mice with LPS to ascertain the role of Nur77 in LPS-induced sepsis in vivo. After treatment with LPS, lungs of Nur77^−/−^ mice had severe inflammatory hyperemia, as evidenced by increased mononuclear cells and erythrocyte infiltration (Fig. [1a](#Fig1){ref-type="fig"}). RT-PCR and Real-time PCR assays, in liver tissues from Nur77^−/−^ mice, showed substantial induction of *Tnf* and *Il6* expression (Fig. [1b](#Fig1){ref-type="fig"}). Consistent with these results, levels of TNFα and IL-6 in serum were significantly higher in LPS-treated Nur77^−/−^ mice than in LPS-treated Nur77^+/+^ mice (Fig. [1c](#Fig1){ref-type="fig"}), suggesting that the host response in Nur77^−/−^ mice is altered. After lethal challenge with LPS, Nur77^−/−^ mouse survival was reduced (Fig. [1d](#Fig1){ref-type="fig"}). These results are consistent with a recent report that mice lacking Nur77 had exacerbated inflammatory and immune responses, and survival was decreased after lethal endotoxemic challenge \[[@CR22]\]. Thus, Nur77 is important for modulation of inflammatory responses during sepsis.Fig. 1Mice deficient in Nur77 are more susceptible to LPS-induced sepsis. **a** Histological analysis of lungs from Nur77^+/+^ and Nur77^−/−^ mice 6 h after challenge with PBS or LPS (20 mg/kg). Representative images are shown. Scale bars, 100 μM. Original magnification, 100x. **b** RT-PCR (left) and Real-time PCR (right) quantification of expression of hepatic *Tnf* and *Il6* mRNA from Nur77^+/+^ and Nur77^−/−^ mice 2 h after challenge with PBS or LPS (20 mg/kg). Error bars represent means ± SD from 3 biological replicates. \**p* \< 0.05 and \*\**p* \< 0.01. **c** ELISA assay of TNFα and IL-6 expression in serum of LPS-treated Nur77^+/+^ mice (n = 5) and LPS-treated Nur77^−/−^ mice (n = 5). Error bars represent means ± SD. \*\**p* \< 0.01. **d** Survival of Nur77^+/+^ mice (n = 7) and Nur77^−/−^ mice (n = 8) treated with LPS and monitored for up to 24 h

To further ascertain the role of Nur77 in sepsis, we treated mice with LPS/D-GalN known to induce acute liver injury. At 5 h after LPS/D-GalN challenge, Nur77^−/−^ mice had severe hepatocyte destruction compared to wild-type mice (Fig. [2a](#Fig2){ref-type="fig"}). LPS/D-GalN injection also promoted hepatocyte cell death in Nur77^−/−^ mice revealed by PARP cleavage (Fig. [2b](#Fig2){ref-type="fig"}). ALT and AST, liver function markers, were also significantly greater in serum from LPS/D-GalN-treated Nur77^−/−^ mice (Fig. [2c](#Fig2){ref-type="fig"}), indicating increased liver necrosis. We also measured TNFα and IL-6 expression as these are known to be involved in this model of acute liver inflammation \[[@CR23], [@CR24]\] in liver tissues from wild-type and Nur77^−/−^ mice. RT-PCR and real-time PCR assays confirmed that expression of these pro-inflammatory cytokines mRNA was greater in LPS/D-GalN-treated Nur77^−/−^ mice than in wild-type mice (Fig. [2d](#Fig2){ref-type="fig"}). Similarly, generation of inflammatory cytokines including TNFα and IL-6 were markedly enhanced in serum from Nur77^−/−^ mice (Fig. [2e](#Fig2){ref-type="fig"}). Thus, Nur77 is protective against LPS-induced acute liver injury.Fig. 2Nur77^−/−^ mice have increased susceptibility to LPS/D-GalN-induced acute liver injury. **a** H&E staining of livers from Nur77^+/+^ and Nur77^−/−^ mice 5 h after injection with LPS/D-GalN. Representative images are shown. Scale bars, 100 μM. Original magnification, 100x. **b** Liver extracts assessed by Western blot and indicated antibodies. **c** ELISA of serum ALT and AST from Nur77^+/+^ and Nur77^−/−^ mice 5 h after injection with LPS/D-GalN or PBS. Error bars represent means ± SD. \**p* \< 0.05 and \*\**p* \< 0.01. **d** *Tnf*, *Il6* and *Il12* mRNA expression was measured with RT-PCR (left) and qPCR (right) in livers from Nur77^+/+^ and Nur77^−/−^ mice 2 h after treatment with LPS/D-GalN. Error bars represent means ± SD from 3 biological replicates. \**p* \< 0.05 and \*\**p* \< 0.01. **e** ELISA quantification of serum TNFα, IL-6 from Nur77^+/+^ and Nur77^−/−^ mice after treatment with LPS/D-GalN for 5 h. Error bars represent means ± SD. \**p* \< 0.05

The molecular mechanism by which Nur77 deficiency promotes sepsis remains obscure. Nur77 has been shown to inhibit LPS-induced inflammation by inhibiting p65 binding to DNA, thereby reducing pro-inflammatory cytokine production \[[@CR25]\]. We observed enhanced phosphorylation and degradation of IκBα was in liver and spleen tissues from Nur77^−/−^ mice challenged with LPS (Fig. [3a](#Fig3){ref-type="fig"}), indicating Nur77 could suppress LPS-induced NF-κB activity in vivo. Also Nur77 contributes to regulation of TRAF6 signalling through its interaction with TRAF6. As shown in Fig. [3b](#Fig3){ref-type="fig"}, mice challenged with LPS for 1 h had enhanced Nur77-TRAF6 interaction in the liver and spleen compared to control PBS-treated mice. These results are consistent with our recent observation that disruption of Nur77-TRAF6 interaction in Nur77^−/−^ mice accelerated the development of IBD \[[@CR6]\]. Collectively, these data suggest that Nur77 physically interacts with TRAF6 in in vivo mouse model of sepsis, revealing a pathophysiological significance of Nur77-TRAF6 interaction in sepsis. Auto-ubiquitination of TRAF6 is required for NF-κB signal transduction \[[@CR16]\]. Here, our results showed that Nur77 deficiency significantly enhanced auto-ubiquitination of TRAF6 in liver and spleen tissues prepared from Nur77^−/−^ but not wild-type mice (Fig. [3c](#Fig3){ref-type="fig"}). At the same time, overexpression of Nur77 significantly impaired LPS-induced TRAF6 auto-ubiquitination (Fig. [3d](#Fig3){ref-type="fig"}). Also we investigated whether Nur77 can affect auto-ubiquitination of TRAF3, another member of the TRAF family but we observed no significant change. Additional file [1](#MOESM1){ref-type="media"}: Figure S1 indicates that overexpression of Nur77 did not affect TRAF3 auto-ubiquitination induced by LPS, suggesting that Nur77 is important in regulating LPS-induced inflammation by targeting TRAF6.Fig. 3Nur77 inhibits inflammatory response in in vivo mouse model of sepsis by interacting with TRAF6 and regulating TRAF6 auto-ubiquitination (**a**) Immunoblot analysis of indicated signalling proteins in liver (left) and spleen (right) from Nur77^+/+^ and Nur77^−/−^ mice 2 h after LPS (20 mg/kg) challenge. **b** Immunoprecipitation and immunoblot of liver and spleen proteins from C57BL/6 mice 1 h after LPS (20 mg/kg) treatment. **c** Immunoprecipitation of endogenous TRAF6 from liver (left) and spleen (right) lysates of LPS-treated Nur77^+/+^ and Nur77^−/−^ mice, and immunoblot of TRAF6 auto-ubiquitination with anti-ubiquitin antibody. **d** Immunoprecipitation of endogenous TRAF6 from lysates of LPS-treated (50 ng/ml) RAW264.7 cells expressing vector or myc-tagged Nur77 plasmid and immunoblotted for TRAF6 auto-ubiquitination with an anti-ubiquitin antibody

In summary, our in vivo study confirmed a critical protective role for the orphan nuclear receptor Nur77 in sepsis and identify a key mechanism for Nur77 in the regulation of TRAF6 signalling through its interaction with TRAF6 in in vivo mouse model of sepsis.

Additional file {#Sec13}
===============

Additional file 1: Figure S1.Nur77 does not affect auto-ubiquitination of TRAF3 induced by LPS. Immunoprecipitation of endogenous TRAF3 from lysates of LPS-treated (50 ng/ml) RAW264.7 cells expressing vector or myc-tagged Nur77 plasmid, immunoblotted for TRAF3 auto-ubiquitination with an anti-ubiquitin antibody. (PDF 62 kb)
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